Synapse - Works

Results (116518)

SRC family kinase inhibition targets YES1 and YAP1 as primary drivers of lung cancer and as mediators of acquired resistance to ALK and epidermal growth factor receptor inhibitors

Journal Article

Sato, H.; Kubota, D.; Qiao, H.; Jungbluth, A.; Rekhtman, N.; Schoenfeld, A. J.; Yu, H. A.; Riely, G. J.; Toyooka, S.; Lovly, C. M.; more...
JCO Precision Oncology (2022)

Fulltext@MSK | Save

Histology-specific prognostication for radiation-associated soft tissue sarcoma

Journal Article

Bartlett, E. K.; Sharma, A.; Seier, K.; Antonescu, C. R.; Agaram, N. P.; Jadeja, B.; Rosenbaum, E.; Chi, P.; Brennan, M. F.; Qin, L. X.; more...
JCO Precision Oncology (2022)

Fulltext@MSK | Save

Risk stratification of stage I grade 3 endometrioid endometrial carcinoma in the era of molecular classification

Journal Article

Zammarrelli, W. A. 3rd; Kim, S. H.; Da Cruz Paula, A.; Rios-Doria, E. V.; Ehmann, S.; Yeoshoua, E.; Hanlon, E. J.; Zhou, Q.; Iasonos, A.; Alektiar, K. M.; more...
JCO Precision Oncology (2022)

Fulltext@MSK | Save

Selpercatinib-induced hypothyroidism through off-target inhibition of type 2 iodothyronine deiodinase

Journal Article

Boucai, L.; Salas-Lucia, F.; Krishnamoorthy, G. P.; Sherman, E.; Rudin, C. M.; Drilon, A.; Bianco, A. C.; Fagin, J. A.
JCO Precision Oncology (2022)

Fulltext@MSK | Save

Matched molecular profiling of cell-free DNA and tumor tissue in patients with advanced clear cell renal cell carcinoma

Journal Article

Kotecha, R. R.; Gedvilaite, E.; Ptashkin, R.; Knezevic, A.; Murray, S.; Johnson, I.; Shapnik, N.; Feldman, D. R.; Carlo, M. I.; Shah, N. J.; more...
JCO Precision Oncology (2022)

Fulltext@MSK | Save

Clinical and genomic characterization of bladder carcinomas with glandular phenotype

Journal Article

Almassi, N.; Whiting, K.; Toubaji, A.; Lenis, A. T.; Jordan, E. J.; Won, H.; Regazzi, A. M.; Chen, Y. B.; Gopalan, A.; Sirintrapun, S. J.; more...
JCO Precision Oncology (2022)

Fulltext@MSK | Save

DICER1-associated anaplastic sarcoma of the kidney with coexisting activating PDGFRA D842V mutations and response to targeted kinase inhibitors in one patient

Journal Article

Antonescu, C. R.; Reuter, V. E.; Keohan, M. L.; Hwang, S.; Chi, P.
JCO Precision Oncology (2022)

Fulltext@MSK | Save

Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers

Journal Article

Hubbeling, H.; Choudhury, N.; Flynn, J.; Zhang, Z. G.; Falcon, C.; Rusch, V. W.; Park, B. J.; Ziv, E.; Shaverdian, N.; Gelblum, D. Y.; more...
JCO Precision Oncology (2022)

Fulltext@MSK | Save

Nuclear oncology: From pathophysiology to clinical applications. 3rd ed

Book Whole

Springer (2022)

Fulltext@MSK | Save

Care at the end of life: Palliative and hospice care—Symptom management

Book Section

Goring, T. N.; Nelson, I. L.
In Sydney, E.; Weinstein, E.; Rucker , L. M. (Eds.) Handbook of Outpatient Medicine. 2nd ed. (2022)

Fulltext@MSK | Save